From: Impact of serum sodium concentrations, and effect modifiers on mortality in the Irish Health System
 | Serum Sodium Category | P -value | |||
---|---|---|---|---|---|
Variable | N |  < 135 mmol/L | 135–145 mmol/L |  > 145 mmol/L | |
Observations n (%) | 32,666 | 2503 (7.7) | 29,908 (91.6) | 255 (0.8) | Â |
Mean Age at baseline (SD) | 32,666 | 65.9 (16.8) | 56.1 (17.9) | 63.3 (18.3) |  < 0.001 |
Sex | |||||
 Women | 17,367 | 48.8 | 53.6 | 44.7 |  |
 Men | 15,299 | 51.2 | 46.4 | 55.3 |  < 0.001 |
Clinical setting at baseline a | |||||
 Emergency Department | 4,835 | 30.1 | 13.5 | 16.9 |  |
 General Practice | 15,293 | 19.7 | 49.4 | 21.2 |  |
 Inpatient | 7,543 | 37.7 | 21.6 | 56.1 |  |
 Outpatient | 4,965 | 12.5 | 15.5 | 5.9 |  < 0.001 |
Markers of renal function | |||||
 Urea (mmol/L) (Median IQR) | 32,666 | 5.3 (3.8–8.2) | 4.9 (3.8–6.2) | 7.9 (5.2–14.1) |  < 0.001 |
 Serum creatinine (µmol/L) (Median IQR) | 32,666 | 81.0 (64.0–108.0) | 77.0 (65.0–91.0) | 97.0 (78.0–140.0) |  < 0.001 |
 Baseline eGFR b (ml/min/1.73m2) (Median IQR) | 32,666 | 76.5 (50.9–93.6) | 86.4 (68.5–101.2) | 63.1 (36.3–86.7) |  < 0.001 |
eGFR Category (ml/min/1.73m2) b | |||||
 eGFR >  = 90 | 13,882 | 30.1 | 43.7 | 20.8 |  |
 eGFR 60–89 | 12,867 | 36.8 | 39.7 | 33.7 |  |
 eGFR 30–59 | 4,755 | 21.9 | 13.8 | 29.8 |  |
 eGFR 15–29 | 814 | 7 | 2 | 11.8 |  |
 eGFR < 15 | 348 | 4.4 | 0.8 | 3.9 |  < 0.001 |
Inflammatory Markers | |||||
 Haemoglobin (g/dl) (Mean SD) | 26,561 | 12.4 (2.1) | 13.5 (1.8) | 12.4 (2.5) |  < 0.001 |
 White blood count (× 109/L) (Median IQR) | 26,561 | 9.2 (6.7–12.7) | 7.2 (5.8–9.4) | 10.5 (7.2–15.0) |  < 0.001 |
 Lymphocyte count (× 109/L) (Median IQR) | 26,561 | 1.2 (0.8–1.7) | 1.7 (1.3–2.2) | 1.3 (0.8–1.9) |  < 0.001 |
 Neutrophil count (× 109/L) (Median IQR) | 26,561 | 6.8 (4.4–10.4) | 4.4 (3.3–6.3) | 8.4 (4.7–12.3) |  < 0.001 |
Nutritional and Metabolic Markers | |||||
 Serum Albumin (g/L) (Mean SD) | 32,666 | 32.6 (7.3) | 37.7 (5.5) | 29.7 (9.5) |  < 0.001 |
 Serum Calcium (mmol/L) (Mean SD) | 32,666 | 2.2(0.2) | 2.3 (0.1) | 2.2 (0.3) |  < 0.001 |
 Serum Phosphorus (mmol/L) (Mean SD) | 32,666 | 1.2(0.4) | 1.2 (0.3) | 1.2 (0.5) |  < 0.001 |
 Serum Potassium (mmol/L) (Mean SD) | 32,666 | 4.3(0.8) | 4.4 (0.5) | 4.1 (0.8) |  < 0.001 |
Lipid related Markers | |||||
 Total Cholesterol (mmol/L) (Mean SD) | 17,188 | 4.7 (1.3) | 5.1 (1.1) | 4.9 (1.2) |  < 0.001 |
 Triglycerides (mmol/L) (Mean SD) | 14,302 | 1.3 (1.1) | 1.4 (0.9) | 1.6 (1.2) |  < 0.001 |
Glycaemic markers | |||||
 Glucose (mmol/L) (Median IQR) | 32,666 | 6.6 (5.4–10.1) | 5.2 (4.8–6.1) | 6.2 (5.2–8.0) |  < 0.001 |
Markers of Liver function | |||||
 Alanine Alkaline phosphatase (IU/L) (Median IQR) | 31,599 | 79.0 (61.0–105.0) | 68.0 (55.0–84.0) | 75.0 (57.2–97.0) |  < 0.001 |
 Alanine transaminase (IU/L) (Median IQR) | 31,131 | 23.0 (17.0–35.0) | 23.0 (17.0–32.0) | 24.0 (18.0–42.0) | 0.018 |
 Gamma-glutamyltransferase (IU/L) (Median IQR) | 31,196 | 34.0 (21.0–67.0) | 24.0 (17.0–39.0) | 31.0 (21.0–70.0) |  < 0.001 |
 Total bilirubin (µmol/L) (Median IQR) | 30,867 | 13.0 (10.0–19.0) | 12.0 (9.0–16.0) | 14.0 (10.0–21.0) |  < 0.001 |